News

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

4 June 2024

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

Avance Clinical is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.

  • Reset
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea – Seoul Office Announced at BIO Korea 2024

9 May 2024

Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea – Seoul Office Announced at BIO Korea 2024

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea.

New Analyst Report – Avance Clinical GlobalReady for Biotechs

12 December 2022

New Analyst Report – Avance Clinical GlobalReady for Biotechs

Frost & Sullivan applies a rigorous analytical process to evaluate multiple nominees for each award category before determining the final award recipient.

Avance Clinical Wins Frost & Sullivan Customer Value Leadership Award 2022

7 December 2022

Avance Clinical Wins Frost & Sullivan Customer Value Leadership Award 2022

After an extensive review by CRO industry analysts comprising executive interviews and background sector research, Frost & Sullivan has recognized Avance Clinical, the leading Australian-based biotech CRO with US operations, with the Frost & Sullivan’s 2022 Asia-Pacific Customer Value Leadership Award.

Avance Clinical Sponsors China BioPharma Award at the Global Scrip Awards, London

27 October 2022

Avance Clinical Sponsors China BioPharma Award at the Global Scrip Awards, London

Avance Clinical, the leading Australian-based biotech CRO with US operations will sponsor and present the China BioPharma Award at the global biotech Scrip Awards in London next month.

Proven industry
experience & expertise

500+

Studies in the past 5 years

330+

Experienced team members

18k+

Participants past 5 years

30

Years of CRO experience